The meta-analyses make a great effort to pool twenty-seven studies that showed digoxin increased the risk of estrogen receptor-positive breast cancer but not others (Osman et al., 2017); however, the heterogeneity of the previous studies might limit the data interpretation. This evidence concerns the gene ESR1 and breast carcinoma.